AstraZeneca Belgium chief warns Europe’s drug access problem is undermining clinical research
08-09-2026
EURACTIV - AstraZeneca's clinical trials have been scaling back in Belgium, with the number of studies run by the company falling by around 20%, according to Angela Thompson, country president of AZ for Belgium and Luxembourg. Read more
Angela Thompson, President of AstraZeneca Belgium and Luxembourg